Chewable Protein Tablets
Soy Rich Proto Energy Crunch Tablets
| $7.99 | Vanilla 100 Ct VP1007R | Retails for $9.90 | |
| $79.99 | Vanilla 12 Bottles 100 Count Each | Retail Value $95.40 | |
| $16.99 | Vanilla 250 Ct VP1007U | Retails for $21.90 | |
| $7.99 | Chocolate 100 Ct VP1008R | Retails for $9.90 | |
| $79.99 | Chocolate 12 Bottles 100 Count Each | Retail Value $95.40 | |
| $16.99 | Chocolate 250 Count VP1008U | Retails for $21.90 | |
|
Display An Attractive 12 Bottle Case On Your Counter for Patient/Client Convenience. Additional Wholesale Discounts Available |
|||
Choose Vanilla or Chocolate flavor
Tweet
These easy-to-take chewable tablets are made with Soya Protein supplying a full spectrum of essential amino acids. They are an ideal high-quality protein supplement for adults, teens and children. As a dietary supplement chew 3 tablets before each meal. To further increase protein intake, chew 3 tablets between meals and at bedtime.
Serving size is 3 tablets. Each 3 tablets contain: 8 Calories, 1400 mg Protein, 600 mg Carbohydrates, 60 mg Fat.
Ingredients: soya protein (powder), non-fat milk, compressable sugar, microcrystalline cellulose, (vanilla: S.D. vanilla flavor, ethyl vanillin) (chocolate: chocolate flavor, lecithenated cocoa), carrageenan, vegetable stearine, silica, magnesium stearate.
Find Protein Supplements at a Featured Merchant (below)
Soy May Reduce Diabetes Risk In Overweight Women
Soy-Based Ingredients, Again Recognized For Benefits In Reducing Risk Of Diabetes, As Well As Supporting Effective Weight Management and Helping Maintain Women's Nutritional Healthcare...
Increased Intakes of Soy and its Isoflavones May Decrease The Risk of Type 2 Diabetes in Overweight Women, Reports A New Study from Japan.
The risk of type 2 diabetes was 40 to 50 per cent lower in overweight women who consumed over 118 grams of soy a day, compared to overweight women who consumed less than 43 grams a day, according to a new study with 25,872 men and 33,919 women aged between 45and 75.
Similar associations were observed when the Japanese researchers considered the isoflavones: daidzein and genistein, according to findings published in the Journal of Nutrition.
"To our knowledge, ours in the first prospective study to examine the association of isoflavone intakes with type 2 diabetes in an apparently healthy population," wrote the researchers, led from the International Medical Center of Japan.
"Furthermore, no previous study to our knowledge has assessed the association between intake of these food factors and type 2 diabetes or glucose intolerance stratified by BMI," they added.
Study details
The team of researchers used a 147-item food frequency questionnaire to carefully assess dietary intakes of soy-based products and isoflavone intakes. Over a five year follow-up period, 1,114 people developed diabetes.
While intakes of soy products and isoflavones were not associated with a significant reduction in the risk of type-2 diabetes in men or all women, the highest intakes of soy products were found to significantly reduce the risk of diabetes in overweight women.
In addition, daidzein and genistein intakes of 22 and 36 milligrams per day, respectively, were associated with a 10 per cent reduction in the risk of diabetes in overweight women, added the researchers.
"The possible protective associations of soy and isoflavone intakes among overweight women deserve further investigation," explained the researchers.
They researchers theorize that the oetrogen-like effects of the isoflavones may be behind the benefits, since oestrogen has been reported to affect genes involved in insulin sensitivity and glucose uptake. Beyond the oetrogen-like effects, they note that isoflavones may inhibit the uptake of glucose in the gut, and also improve energy metabolism.
A role for soy protein was also considered, with previous studies reporting that protein may improve insulin resistance.
"The results of this large, well-conducted study suggest a protective association among overweight women consuming soy. This research further shows that soy has many associated health benefits, including those related to weight management and satiety" they added.
An estimated 19 million people are affected by diabetes in the Europe, equal to four per cent of the total population. This figure is projected to increase to 26 million by 2030.
In the US, there are almost 24 million people with diabetes, equal to 8 per cent of the population. The total costs are thought to be as much as $174 billion, with $116 billion being direct costs from medication, according to 2005-2007 American Diabetes Association figures.
Source: Journal of Nutrition (Published online ) "Soy Product and Isoflavone Intakes Are Associated with a Lower Risk of Type 2 Diabetes in Overweight Japanese Women"
